Associations of Plasma 3-Methylhistidine with Frailty Status in French Cohorts of the FRAILOMIC Initiative

Frailty and sarcopenia are characterized by a loss of muscle mass and functionality and are diagnosed mainly by functional tests and imaging parameters. However, more muscle specific biomarkers are needed to improve frailty diagnosis. Plasma 3-methylhistidine (3-MH), as well as the 3-MH-to-creatinin...

Descripción completa

Detalles Bibliográficos
Autores principales: Kochlik, Bastian, Stuetz, Wolfgang, Pérès, Karine, Féart, Catherine, Tegner, Jesper, Rodriguez-Mañas, Leocadio, Grune, Tilman, Weber, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678434/
https://www.ncbi.nlm.nih.gov/pubmed/31295923
http://dx.doi.org/10.3390/jcm8071010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678434/
https://www.ncbi.nlm.nih.gov/pubmed/31295923
http://dx.doi.org/10.3390/jcm8071010

Ejemplares similares